The title binuclear platinum(II) complex was prepared in afourstep reaction. First, K 2PtCl4 (2.0 mmol in 50 ml water) reacted with potassium iodide (4.0 mmol) to produce the cis- [PtCl 2I2] 2-. In the second step, amixture of the cis isomer and potassium oxalate monohydrate (2.5 mmol) was stirred at 343 Kfor 1day. The light green powder product was filtered, washed with distilled water and re-crystallized from hot (343 K) distilled water. Green needle-like crystals were obtained by drying in the air at 313 K (yield 80 %). Third, after adding the desired ammonium nitrate the mixture was adjusted to pH =7w ith NaOH solution and stirred at 323 Kf or 3h ,p roducing the intermediate product 98 mmol). The mixture was allowed to stir in the dark place. As the AgI was removed, the mixture was stirred for further 12 hat room temperature. Filtering off the remaining solid, alight yellow solution was obtained. The filtrate was left at room temperature for slow evaporation. Light yellow crystals suitable for X-ray diffraction analysis were obtained in the air at 313 K during two weeks (yield 56 %).
Source of material
The title binuclear platinum(II) complex was prepared in afourstep reaction. First, K 2PtCl4 (2.0 mmol in 50 ml water) reacted with potassium iodide (4.0 mmol) to produce the cis-[PtCl 2I2] 2-. In the second step, amixture of the cis isomer and potassium oxalate monohydrate (2.5 mmol) was stirred at 343 Kfor 1day. The light green powder product was filtered, washed with distilled water and re-crystallized from hot (343 K) distilled water. Green needle-like crystals were obtained by drying in the air at 313 K (yield 80 %). Third, after adding the desired ammonium nitrate the mixture was adjusted to pH =7w ith NaOH solution and stirred at 323 Kf 98 mmol). The mixture was allowed to stir in the dark place. As the AgI was removed, the mixture was stirred for further 12 hat room temperature. Filtering off the remaining solid, alight yellow solution was obtained. The filtrate was left at room temperature for slow evaporation. Light yellow crystals suitable for X-ray diffraction analysis were obtained in the air at 313 K during two weeks (yield 56 %).
Discussion
The use of Cisplatin in cancer chemotherapy was initiated by [1] . Since this discovery, other platinum compounds such as Carboplatin and Oxaliplatin have become available for the treatment of cancer [2, 3] . In order to improve activity and to reduce toxicity, much attention has been focused on designing Cisplatin analogues with reduced toxicity and/or broader antitumor spectrum, leading to successful developmentof several new anticancer platinum drugs including Nedaplatin, Lobaplatin and Eptaplatin. The title crystal structure is comprised of binuclear
2+ cations and nitrate anions. The two Pt(II) atoms are crystallographically identical. Each Pt(II) is in a square pyramidal coordination by one Pt(II) atom, two amine N atoms, one O atom of water molecule and one carboxylate O atom of acetate. The latter four ligands form the basal plane, while another Pt(II) atom occupies the apical site. The O1W atom as the bridging ligand links the two center metal Pt(II) cations. There is a direct interaction between two Pt(II) atoms with a Pt1-Pt1 bond distance of 3.1649(7) Å, which is shorter than the van der Waals contact distance for Pt-Pt of 3.40 Å [4, 5] . In addition, an intramolecular hydrogen bond is formed from one O atom of nitrate anion and two amine with d(N1-H1A···O5) = 2.884 Å and ∠N1-H1A···O5 = 172.05°. In the unit cell, each molecule is involved in three types of intermolecular hydrogen bonds. One occurs between the nitrate anion oxygen group and the amine nitrogen group of the next two molecules, another type is between the nitrate anion oxygen group and the bridging water molecule, the third type is between the O atoms of nitrate anion and the amine of the next molecule. Through these hydrogen bonds, the title molecules are linked into a three-dimensional framework. 
